Biopharm Analytica

Biotechnology and Pharmaceutical Business News Service

HOME

MY ACCOUNT

CONTACT US

ABOUT US

NEWS

NEWS ARCHIVE

REPORTS

EVENTS

COMPANIES

WHOS WHO

IMAGE LIBRARY

CONSULTING SERVICES

LINKS

	SEARCH


			GO

NEWS
Archive

Please select a year:

September 2010

1/9/2010 Oriola-KD Acquire 70-Strong Moscow Pharmacy Network for U.S.$15.35 Million

August 2010

31/8/2010 Russia's Pharmsynthez Plans to Raise U.S.$16 Million in IPO
27/8/2010 Pharmstandard H1 2010 Sales Increase by 14.7 Per Cent to U.S.$375.8 Million
26/8/2010 Serbia's Galenika to Open Pharmaceutical Packaging Facility in Russia
26/8/2010 Latvia's Grindeks Reports H1 Net Profit Growth of 20.6 Per Cent to U.S.$7.35 Million
24/8/2010 Leading Russian Diagnostic Reagents Company Secures Credit of U.S.$6.5 Million
24/8/2010 Kirov Company Acquires 75 Per Cent of Shares in Local Pharmacy Chain for U.S.$3.75 Million
20/8/2010 Ferein Set to Construct Large-Scale Pharma Manufacturing Plant in Belarus
18/8/2010 Grindeks to Collaborate More Closely with Latvian Institute of Organic Synthesis
18/8/2010 Medvedev Signs Decree to Pull Russia Out of International Science & Technology Centre
13/8/2010 Report Notes 38 Per Cent Increase in Number of Clinical Trials Approved in Russia During Q2 2010
13/8/2010 Stada Sales in Russia Increase by 24 Per Cent in H1 2010 to U.S.$124 Million
11/8/2010 Russia's Protek Report 16 Per Cent Sales Rise in Q2 2010 to U.S.$767 Million

July 2010

23/7/2010 Candidate HIV Vaccine Developed in Novosibirsk Wins Approval for Clinical Trials
23/7/2010 New Report Estimates Belarus Pharma Market to Grow to U.S.$1.05 Billion by 2014
22/7/2010 U.S.$250-300 Million Irkutsk Biobutanol Project Set for Relaunch in September 2010
21/7/2010 Biokad & Geropharm to Invest U.S.$69 Million in Establishing St. Petersburg Pharma Production
20/7/2010 Thermo Fisher Scientific Completes U.S.$260 Million Acquisition of Lithuania's Fermentas
20/7/2010 Chelyabinsk's Klassika Acquires 11 Pharmacies in Ekaterinburg for U.S.$1.63 Million
16/7/2010 New Report Forecasts U.S.$ 22.4 Per Cent Growth in Russian Pharma Sector in 2010
15/7/2010 Veropharm Report 3.4 Per Cent Decrease in Q1 2010 Profit to U.S.$3.97 Million
14/7/2010 List Released of Strategic Drugs to be Manufactured within Russia
14/7/2010 Russian Academy of Sciences to Form New Institute of Cell & Molecular Biology in Novosibirsk
13/7/2010 Merck Serono's Cladribine Tablets for MS Approved in Russia
13/7/2010 Kazakhstan Government Approves Programme for Development of Pharma Industry 2010-2014
9/7/2010 Russia Plans to Manufacture 57 Strategically Important Drugs by 2015
7/7/2010 Russian Pharma Testing Facility Receives U.S.$2.1 Million Support to Achieve International Accreditation
6/7/2010 Rusnano to Invest in U.S.$163.9 Million Innovative Drugs Project
6/7/2010 Russian Ministry of Economic Development Allocates U.S.$6.5 Million Funding for Anti-Viral Preparation
5/7/2010 Russia's Pharmsynthez Company Plans U.S.$16 Million IPO
2/7/2010 Russian Venture Company to Launch U.S.$48 Million Biopharmaceutical Fund
2/7/2010 Vertex Announce Plans to Construct U.S.$31-37.5 Million Pharma Plant in St. Petersburg
1/7/2010 Latvian Drug Discovery Institute Sells 6 Patents to Pharma Companies

June 2010

30/6/2010 Russia Maintains Interest in Novel Phage Anti-Bacterial Therapies
25/6/2010 Favea Sign Agreement for Supply of Equipment to Pharma Companies in Tatarstan
24/6/2010 Israel's Teva Plan Construction of U.S.$100 Million Pharma Plant in Russia
24/6/2010 Pharmacy Chain 36.6 Reduces Net Loss to U.S.$11.56 Million in FY 2009
10/6/2010 Kurchatov Institute Invests U.S.$7 Million in Equipment to Sequence First Russian Human Genome
10/6/2010 Volgograd Looks to Establish U.S.$110 Million Pharmaceutical Cluster
9/6/2010 Russian Businessman Fined for Attempted Bribery of Deputy Director of Virology Centre
9/6/2010 Pharmacy Chain 36.6 Plans to Raise U.S.$29.3 Million From Additional Share Issue
7/6/2010 Russia's Protek Report 4.4 Per Cent Sales Rise in Q1 2010 to U.S.$702.5 Million
7/6/2010 Russian Seed Fund Invests in Biotech Project to Develop Therapeutic mAbs Against Kidney Cancer
3/6/2010 Leading American CRO to Participate in U.S.$51.7 Million Project to Create Major Preclinical Studies Centre Outside Moscow
3/6/2010 U.S. & Ukraine Agree to Share Standards for Quality of Medicines
3/6/2010 Russia's Materia Medica Reports on Effectiveness of Anaferon Against Influenza A Virus (H1N1/09)
2/6/2010 Olainfarm Profits Soar by 50 Per Cent in Q1 2010 to U.S.$1.2 Million
1/6/2010 UK's Angel Sign U.S.$1.88 Million Manufacturing Contract with Russia's Materia Medica
1/6/2010 Ukrainian-Belgian JV Plans to Invest U.S.$18 Million in Production of Pharma Substances & Drugs

May 2010

28/5/2010 New Molecular & Cell Biology Institute May be Created in Novosibirsk
27/5/2010 Latvia's Grindeks Reports Net Profit of U.S.$2.43 Million in Q1 2010
27/5/2010 Construction of Peptide Drug R & D and Production Complex Envisaged in Pushkin
27/5/2010 Thermo Fisher Scientific Sign Agreement to Acquire Lithuania's Fermentas for U.S.$260 Million
26/5/2010 Russian Academy of Sciences Reports on Development of Novel Peptide Drugs
24/5/2010 UK's Angel Biotechnology Secure Contracts Worth U.S.$476,420 with Russia's Materia Medica
20/5/2010 Putin Promises U.S.$1.6 Billion for Russian Academy of Sciences in 2010
19/5/2010 Report Notes 18 Per Cent Increase in Number of Clinical Trials Approved During Q1 2010 in Russia
19/5/2010 Burrill & Company Discuss Creation of Biotechnology Venture Fund in Tatarstan
17/5/2010 Novo Nordisk Discuss Prospects for Expanding Presence in Russian Market
14/5/2010 Veropharm's Net Profit Rises by 20 Per Cent to U.S.$36.5 Million
11/5/2010 Russia's Sistema Express Interest in Andhra Pradesh Pharma and Biotech
6/5/2010 Rusnano and MP Biomedicals Sign Nanobiotechnology Cooperation Agreement
6/5/2010 Meeting Discusses EU-Russia Cooperation in Standardisation & Integration of Virus Collections
4/5/2010 Russian Government Approves Sale of U.S.$36.8 Million Bioton Vostok Stake to Sanofi-Aventis

April 2010

29/4/2010 Pharmstandard Profits Increase by 96 Per Cent to U.S.$234.4 Million
29/4/2010 Latvia's Grindeks Reports 60 Per Cent Fall in Profits to U.S.$6.74 Million
29/4/2010 Gedeon Richter Increase Stake in Russia's Protek with U.S.$26.45 Million Share Purchase
28/4/2010 Novo Nordisk Sign Agreement to Construct Russian Insulin Plant with Potential Investment of U.S.$80-100 Million
27/4/2010 Russia's Protek Raises Around U.S.$400 in Successful IPO
27/4/2010 GE Healthcare and Nycomed to Form JV to Sell, Market & Distribute Medical Diagnostic Contrast Agents in Russia and CIS
26/4/2010 Cleveland BioLabs Triggers U.S.$5.7 Million Investment in JV with Russian VC Fund
22/4/2010 U.S.$53 Million Vaccine & Therapeutic Biopharmaceuticals Plant to be Constructed in Yaroslavl' Region
22/4/2010 Kazakh Prime Minister Visits National Biotechnology Centre in Astana
21/4/2010 Oriola-KD Reports Difficult Market Conditions in Russia
21/4/2010 Russian Government Aims to Create Environment for Investment in Pharma Sector
21/4/2010 Affitech Signs Strategic Alliance with Russian Biotech Partner
19/4/2010 Putin Conducts Unscheduled Check of Pharmaceutical Prices in Murmansk Pharmacy
19/4/2010 UK's Angel Biotechnology Sign c.U.S.$2.3 Million Contract with Russia's Materia Medica
16/4/2010 Eurasian Federation of Biotechnology Established in Moscow
15/4/2010 Russia's Protek Seeks Up to U.S.$2.12 Billion Value in Moscow IPO
15/4/2010 Russia's Pharmacy Chain 36.6 Report 19.1 Per Cent Fall in Sales to U.S.$726 Million
14/4/2010 Putin Supports Mutually Beneficial Partnership with International Pharma Companies
14/4/2010 Mexico's Probiomed to Manufacture Recombinant Vaccines in Tartarstan
13/4/2010 Latvia's Grindeks Plans to Increase 2010 Turnover to U.S.$134 Million
13/4/2010 Russian Anti-Viral Preparation to be Certified by Slovak Academy of Sciences
13/4/2010 Veropharm's IFRS 9M 2009 Net Profit Grows by 15 Per Cent to U.S.$25.1 Million
12/4/2010 Russia's Pharmstandard Acquires 11.3 Per Cent of Shares of Latvia's Grindeks Pharma Company
12/4/2010 Gerresheimer Targets Russia's Fast-Growing Pharma Market
1/4/2010 Construction Begins of U.S.-Funded Pathogens Lab in Almaty
1/4/2010 Pfizer Emerges as One of World's Clinical Trial Leaders in Russia
1/4/2010 Stada Sales in Russia Increase by 5 per cent to U.S.$259 Million
1/4/2010 KhimRar & R-Pharm to Create Drug Substances JV in Yaroslavl'

March 2010

31/3/2010 U.S.$10.85 Million SPF Facility Opens in Novosibirsk
31/3/2010 UK Provides Assistance to Key Georgian Plant Diseases Institute
31/3/2010 Latvia's Olainfarm Plans Expansion Into Asia
30/3/2010 Russian Pharma Company Protek Plans U.S.$400 Million IPO
25/3/2010 Russia to Allocate More Than U.S.$16.9 Million to Manufacture of Radiopharmaceuticals
24/3/2010 Russian Academy of Sciences' Siberian Branch Set to Open Biotechnology Centre in Korea
23/3/2010 Russia's Tartarstan Adopts U.S.$1 Billion Biotechnology Programme
22/3/2010 AstraZeneca Considers Launch of Manufacturing in Russia
22/3/2010 Menarini/Berlin-Chemie Announce U.S.$40 Million Investment in New Russian Production Plant
19/3/2010 Favea Win U.S.$461,000 Contract for Design of Belarus Pharma Plant
14/3/2010 U.S.Pharma Manufacturers Urge Support for International Standards in Russian Medicines Law
9/3/2010 Thefts Prevented at Russian Virology Centre
8/3/2010 New Report Notes 6 Per Cent Decline in Numbers of Clinical Trials Approved in Russia
4/3/2010 Russian Corporation Set to Begin Construction of U.S.$150.8 Million Pharma Facility in Samara
2/3/2010 U.S.$136 Million Kirov Blood Plasma Fractionizing Plant Scheduled for Completion in 2010
1/3/2010 Latvia's Olainfarm Reports Record Profit of U.S.$4.88 Million in 2009

February 2010

26/2/2010 Net Profit of Latvia's Grindeks Falls by 58.9 Per Cent to U.S.$7.1 Million
25/2/2010 Russian Company Secures Rusnano Investment in U.S.$60 Million Project to Develop Drugs Against Age-Related Illnesses
25/2/2010 Minsk Institute to Create Facility for Production of Pharma Substances
18/2/2010 European Union Discuss U.S.$4 Million Funding for Crimean Anti-Plague Facility
17/2/2010 Biotechnology Park to be Created in Novosibirsk Region
17/2/2010 Visit of Rusnano Delegation to Kirov Focuses on Nanobiotechnology
16/2/2010 Russia to Invest U.S.$66.35 Million in New Influenza Vaccine Facility
15/2/2010 Rusnano & Medsintez Invest in U.S.$129 Million Nanodrugs Project
15/2/2010 Russia & India to Cooperate in Biotechnology
15/2/2010 Rusnano & Medical-Biological Agency Sign Agreement on Safe Application of Nanotechnology
12/2/2010 Major Indian Pharma Delegation to Visit Belarus
12/2/2010 Russia's President Medvedev Calls for Creation of Advanced, Innovative Pharma Companies
11/2/2010 Pharmstandard 2009 Revenue Increases by 68.1 Per Cent to U.S.$797 Million
11/2/2010 Net Sales Growth (RUR) of Oriola-KD in Russia Exceeds 40 Per Cent in 2009
10/2/2010 Russia's Gerofarm Plans to Invest U.S.$34.5 Million in St. Petersburg Pharma Plant
10/2/2010 Biokad Reported to be Planning Construction of U.S.$15-20 Million Pharma Plant in St. Petersburg
9/2/2010 Russian Health Official Sacked for Opposing Legislation to Regulate Pharma Pricing
9/2/2010 Czech Specialists to Participate in Construction of Russian Influenza Vaccines Plant
8/2/2010 Russian Biotech Companies Seek Indian Partners for Joint Ventures
5/2/2010 Bayer Open New Pharmaceutical Logistics Centre in Russia
3/2/2010 Latvia's Grindeks Completes Successful Clinical Trials of Mildronate
1/2/2010 Russian Vaccine Manufacturer Releases Products Valued at U.S.$86.2 Million in 2009

January 2010

28/1/2010 U.S.$6.4 Million to be Allocated to Russian Molecular Biology Research
27/1/2010 2010 Opening Scheduled for Schott's cGMP Pharma Packaging Plant in Russia
25/1/2010 Researchers in Minsk Develop New Antiviral Preparation
25/1/2010 Latvian Biotechnology Association to Participate in Central European BioForum
22/1/2010 Hungary's Omninvest Development to Invest U.S.$100 Million in Uzbekistan Pharma Facility
21/1/2010 Russian VC Fund Set to Contribute U.S.$18 Million to JV with Cleveland Biolabs
21/1/2010 U.S.$16.8 Investment Scheduled for Sverdlovsk Pharma Plant in 2010-2015
20/1/2010 Biotechnology Development & Pilot Production Centre Opens in Minsk
20/1/2010 SIA International Acquire 25 Per Cent of Pharmacy Chain 36.6
20/1/2010 U.S.$93 Million Antibiotics & Anti-Cancer Drugs Plant Slated for Russia's Lipetsk Region
19/1/2010 Rusnano to Invest in U.S.$28 Million Pharmaceutical Nanotechnology Project
19/1/2010 U.S.$100 Million Investment Planned in Tashkent Vaccine Plant
18/1/2010 Researchers from Kazakhstan & Belarus to Collaborate in Genetics, Biotech & Biosecurity
15/1/2010 Urals' Scientists Outline Plans for the Creation of a Pharmaceutical Cluster
14/1/2010 Lekko to Supply Genetically Engineered Blood-Clotting Factor to Russian Market
12/1/2010 Russian Government to Allocate U.S.$4.9 Million for Pilot Production of mAb-Based Substances & Drugs
11/1/2010 Kazakhstan's Prime Minister Visits Karaganda Pharma Facility
11/1/2010 U.S.-Funded Pathogens Lab Opens in Kazakhstan
11/1/2010 UK's Angel Sign c.U.S.$177,876 Contract for Regulatory Consultancy with Russia's Materia Medica
8/1/2010 Ukraine Invests U.S.$1.6 Million in New Biotechnology Centre
5/1/2010 Construction of Biological Pesticides Plant Planned in Kyrgyzstan
4/1/2010 Rusnano to Invest U.S.$42.9 Million in Production of Nanoliposomal Anti-Cancer Drugs at Urals' Pharma Facility